Biossil
Latest round
- —
Last raised
- Sep 2026
Total raised
- $153M
Investors
- 10
About Biossil
a. Biossil operates as a biotechnology company that focuses on developing therapies for biologically defined patient sub-populations in challenging diseases by leveraging its applied AI drug discovery platform. The company's Excavate software leverages a trillion-point multiomics pipeline alongside population-scale Electronic Medical Records (EMR) data to uncover disease variability and identify treatment-informing endotypes. Biossil's pipeline encompasses precision candidates targeting clinically variable diseases, with a focus on rare and neglected diseases, prophylactic vaccines, and chronic conditions exhibiting multiple disease phenotypes.
Who invested in Biossil
10 investors across 2 rounds
See all investors in Biossil
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biossil
Who invested in Biossil?
Biossil has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biossil raised?
Biossil has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
What does Biossil do?
Biossil is a biotechnology company.
Where is Biossil headquartered?
Biossil is headquartered in Toronto, Canada.
Which VCs invest in companies like Biossil?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Biossil's stage. Their profiles are linked below.
VCs backing biotechnology startups
Raising like Biossil? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.